Micron Appears Undervalued at 29.86x P/E, 3.8x Book Below Sector

Micron trades at a P/E of 29.86x with a P/B of 3.8x, elevated versus historical averages, yet justified by 49% revenue growth and 17.2% ROE driven by unprecedented AI memory demand and HBM shortages extending into 2027.

Micron's 29.86 P/E and 3.8 P/B reflect a 59/100 valuation score, pricing in robust AI-driven HBM and data center demand amid NAND revenue growth to $2.7B. With 17.2% ROE supporting memory cycle recovery, the multiples suit its competitive semiconductor position, though investors must balance cyclical risks against 278% FY2026 earnings growth forecasts.

Relative Valuation

Micron Technology trades at a P/E ratio of 29.86 and P/B of 3.8, with a market cap of $267.1B and valuation score of 59/100. Compared to its intrinsic value of 426.79 USD versus the current price of 285.41 USD, MU appears undervalued by 33% per DCF and relative models. This suggests the market may not fully price in Micron's strong positioning in AI and data center memory markets.

Historical Context

Over the past decade, Micron has shown revenue growth from $12.4B in 2016 to recent levels supporting $42.3B revenue and $11.9B net income. Its ROE of 17.2% reflects improved profitability amid memory cycle recoveries. Historically low price-to-free-cash-flow multiples around 10.7x indicate current valuations remain attractive relative to past trends.

Growth-Adjusted Metrics

Micron's profitability score is 54/100 and solvency score 86/100, bolstered by $10.3B in cash and a robust balance sheet with $49.2B in PP&E for manufacturing. Wall Street's average price target of 294.82 USD implies modest upside from 285.41 USD, adjusted for growth in high-margin AI applications. Strategic investments in R&D position MU for sustained growth despite cyclical semiconductor dynamics.

Micron (MU) trades at a P/E of 29.86, P/B of 3.8, with ROE at 17.2% and a Valuation Score of 59/100, suggesting fair value amid AI-driven memory demand. HBM shortages and GPU growth could drive 30-80% upside into 2026, though watch for pricing peaks and capacity ramps as risks. Investors should monitor FQ2 revenue guidance and analyst target revisions for multiple expansion potential. (62 words)